Strategic Developments in the CD47 Targeting Therapeutics Market
The CD47 Targeting Therapeutics Market is experiencing a transformative phase as it adapts to the pressing challenges posed by global cancer rates. The market size is set to rise dramatically, projected to grow from USD 2.413 billion to an astounding USD 23.3 billion by 2035. Such growth illustrates a compound annual growth rate (CAGR) of 22.89% over this period. The increasing demand for...
0 Comentários 0 Compartilhamentos 230 Visualizações 0 Anterior